ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,875
-0,90%
Bitcoin
62 045,36
4,95%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Lifecore Biomedical Inc (LFCR)

  7. Lifecore Biomedical Inc (LFCR) Actualités

LFCR Lifecore Biomedical Inc

6,43
0,08 (1,26%)
Dernière mise à jour : 21:50:02
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Lifecore Biomedical Inc LFCR NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,08 1,26% 6,43 21:50:02
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
6,43 6,26 6,51 6,35
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
19/4/202422:30GLOBELifecore Biomedical, Inc. Receives Notice from Nasdaq..
01/4/202414:00GLOBELifecore Biomedical Provides Business Update Outlining..
26/3/202421:30GLOBELifecore Biomedical Announces Pending Change of Auditor and..
20/3/202412:30GLOBELifecore Biomedical Concludes Strategic Evaluation Process,..
20/3/202412:00GLOBELifecore Biomedical Completes Restatements and Files Form..
29/2/202422:25EDGAR2Form SC 13D/A - General statement of acquisition of..
16/2/202422:12EDGAR2Form 8-K - Current report
16/2/202422:05GLOBELifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice..
14/2/202421:39EDGAR2Form SCHEDULE 13G - Statement of acquisition of beneficial..
03/2/202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202400:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202400:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202400:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202400:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202400:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202420:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202422:51EDGAR2Form 8-K - Current report
12/1/202422:43GLOBELifecore Biomedical, Inc. Receives Notice from Nasdaq..
11/1/202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202423:22EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
05/1/202422:09EDGAR2Form 8-K - Current report
05/1/202414:00GLOBELifecore Biomedical Expands Relationship with Existing..
04/1/202422:00EDGAR2Form SC 13D/A - General statement of acquisition of..
13/12/202313:30GLOBELifecore Biomedical Provides Business Update
20/11/202322:09EDGAR2Form 8-K - Current report
20/11/202322:05GLOBECompany Reaches Favorable Resolution Regarding..
31/10/202311:17EDGAR2Form 8-K - Current report
18/10/202322:07EDGAR2Form 8-K - Current report
18/10/202322:05GLOBELifecore Biomedical, Inc. Receives Notice from Nasdaq..
17/10/202311:00PRNUSSHL Medical and Lifecore Biomedical enter co-marketing..
10/10/202322:07EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
10/10/202322:05GLOBELifecore Biomedical Provides Update for Development..
31/8/202313:39EDGAR2Form 8-K - Current report
31/8/202313:30GLOBELifecore Biomedical Reports Fourth Quarter and Full Fiscal..
22/8/202322:11EDGAR2Form 8-K - Current report
22/8/202322:06GLOBELifecore Biomedical Sets Fourth Quarter 2023 Earnings..
22/8/202322:05GLOBELifecore Biomedical, Inc. Receives Notice from Nasdaq..
15/8/202323:07EDGAR2Form SC 13D/A - General statement of acquisition of..
14/8/202322:11EDGAR2Form NT 10-K - Notification of inability to timely file Form..
07/7/202322:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
30/6/202320:46EDGAR2Form SC 13G - Statement of acquisition of beneficial..
28/6/202322:32EDGAR2Form SC 13D/A - General statement of acquisition of..
01/6/202313:15GLOBELifecore Biomedical Reports Third Quarter Fiscal Year 2023..
22/5/202322:51GLOBELifecore Biomedical Enters into $150.0 Million in New..
22/5/202322:49GLOBELifecore Biomedical Sets Third Quarter 2023 Earnings..

Dernières Valeurs Consultées

NASDAQ
LFCR
Lifecore Biomedical
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés